(Q30444490)

21 June 2017

1 reference

title

RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation (English)

1 reference

21 June 2017

Michael A Harding

1

0 references

author name string

Dan Theodorescu

series ordinal

2

1 reference

21 June 2017

1 September 2007

1 reference

21 June 2017

1 reference

21 June 2017

25

1 reference

21 June 2017

401-406

1 reference

21 June 2017

5

1 reference

Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

7 January 2021

Focus on bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Cancer metastasis: building a framework

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Delineation of prognostic biomarkers in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Gene-expression profiles predict survival of patients with lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Diversity of gene expression in adenocarcinoma of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

GDIs: central regulatory molecules in Rho GTPase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Structure-activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Review Article: The Role of Ras Superfamily Proteins in Bladder Cancer Progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

RhoGDI2 is an invasion and metastasis suppressor gene in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

The endothelin axis: emerging role in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

Neuromedin U and its receptors: structure, function, and physiological roles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.006

10.1016/J.UROLONC.2007.05.006

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference

PubMed ID

17826660